Elite Health Systems Inc.
EHSIOTCHealthcare · Services-Specialty Outpatient Facilities, NEC · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $1.0M | $0 | $0 | $0 | $1.1M | $3.2M |
| Operating income | −$3.8M | −$1.8M | −$765,000 | −$1.4M | −$88,000 | $1.6M |
| Net income | −$7.8M | −$2.1M | −$816,000 | −$1.3M | −$881,000 | $533,000 |
| Total assets | $6.7M | $4.3M | $1.3M | $1.7M | $3.7M | $4.2M |
| Total liabilities | $1.4M | $143,000 | $676,000 | $291,000 | $660,000 | $487,000 |
| Equity | $5.3M | $4.2M | $645,000 | $1.2M | $2.6M | $3.7M |
| EPS (diluted) | $-0.35 | $-0.13 | $-0.17 | $-0.17 | $-0.11 | $0.07 |
| Shares out. | 21.4M | 13.3M | 7.8M | 7.8M | 7.8M | 7.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −374.9%
- Net margin
- −762.1%
- Return on equity
- −146.9%
- Return on assets
- −117.1%
- Return on capital (ROCE)
- −72.1%
- Liabilities / assets
- 20.3%
- Debt / equity
- 0.25×
- Book value / share
- $0.25
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -2.64distress
- Accruals / assets
- −73.0%clean
- Piotroski F-Score
- 2/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 3 warning● 2 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Jeereddi Prasad AnjaneyaActivist (13D)Dec 29, 2025
- Allen Holding Inc /NyPassive (13G)Feb 26, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 1,179 | 1.0 | +194.8% |
| Apr 30, 2026 | 400 | 1.0 | -15.3% |
| Apr 15, 2026 | 472 | 4.5 | 0.0% |
| Mar 31, 2026 | 472 | 1.0 | 0.0% |
| Mar 13, 2026 | 472 | 1.0 | -9.6% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.